ACUR Stock - Acura Pharmaceuticals, Inc.
Unlock GoAI Insights for ACUR
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|
| Revenue | $1.56M | $3.57M | $2.66M | $410,000 | $2.97M |
| Gross Profit | $1.47M | $3.57M | $2.65M | $408,241 | $2.84M |
| Gross Margin | 94.2% | 99.9% | 99.9% | 99.6% | 95.7% |
| Operating Income | $-1,214,000 | $-758,000 | $-725,000 | $-3,915,000 | $-5,225,000 |
| Net Income | $-879,000 | $-1,208,000 | $-3,774,000 | $-3,842,000 | $-5,682,000 |
| Net Margin | -56.2% | -33.8% | -142.0% | -937.1% | -191.6% |
| EPS | $-0.02 | $-0.04 | $-0.14 | $-0.18 | $-0.36 |
Acura Pharmaceuticals, Inc., an innovative drug delivery company, engages in the research, development, and commercialization of technologies and products to address safe use of medications in the United States. It offers Oxaydo tablets, a Schedule II narcotic indicated for the management of acute and chronic moderate to severe pain; and Nexafed products, which are pseudoephedrine and acetaminophen tablets that are used as nasal decongestants in various non-prescription and prescription cold, sinus, and allergy products. The company has six additional opioid products in various stages of formulation development. Acura Pharmaceuticals, Inc. has collaboration and license agreements with Egalet US, Inc.; and Egalet Ltd. to manufacture and commercialize Oxaydo products worldwide; and development and commercialization agreement with Abuse Deterrent Pharma, LLC to develop LTX-03, an immediate-release tablets utilizing LIMITx technology. The company was incorporated in 1935 and is based in Palatine, Illinois.
Visit WebsiteEarnings History & Surprises
ACUREPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2023 | Aug 7, 2023 | — | — | — | — |
Q2 2023 | May 19, 2023 | — | — | — | — |
Q1 2023 | Mar 3, 2023 | — | — | — | — |
Q3 2022 | Jul 4, 2022 | — | — | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.00 | — | — |
Q4 2021 | Nov 15, 2021 | — | $-0.00 | — | — |
Q3 2021 | Aug 16, 2021 | — | $-0.01 | — | — |
Q2 2021 | May 18, 2021 | — | $-0.01 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.01 | — | — |
Q4 2020 | Nov 16, 2020 | — | $-0.02 | — | — |
Q3 2020 | Aug 14, 2020 | — | $0.01 | — | — |
Q1 2020 | Mar 30, 2020 | — | $-0.02 | — | — |
Q1 2020 | Feb 28, 2020 | — | $0.00 | — | — |
Q4 2019 | Oct 1, 2019 | — | $-0.04 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.15 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.04 | — | — |
Q4 2018 | Dec 31, 2018 | — | $0.00 | — | — |
Q4 2018 | Nov 27, 2018 | — | $-0.05 | — | — |
Q3 2018 | Aug 14, 2018 | — | $-0.06 | — | — |
Q2 2018 | Jun 7, 2018 | — | $-0.08 | — | — |
Latest News
Frequently Asked Questions about ACUR
What is ACUR's current stock price?
What is the analyst price target for ACUR?
What sector is Acura Pharmaceuticals, Inc. in?
What is ACUR's market cap?
Does ACUR pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to ACUR for comparison